GMP Manufacturing Services for mRNA and LNP
Products
Information
ARCALIS provides GMP-compliant manufacturing of mRNA and LNP formulation services, including commercial-scale production. With its facilities in Minamisoma, Japan, ARCALIS supports flexible batch sizes, technology transfer, and regulatory documentation. Notably, ARCALIS was selected as the manufacturing partner for KOSTAIVE(R), the first self-amplifying mRNA (saRNA) COVID-19 vaccine approved in Japan, demonstrating its capability in commercial production of next-generation mRNA vaccines.
